A 身体的苦痛・生命予後

A1.GemLo B, Rayner AA, Lewis B, et al.

Home support of patients with end-stage malignant bowel obstruction using hydration and venting gastrostomy.

Am J Surg. 1986; 152: 100-4.


A2.Moley JF, August D, Norton JA, et al.
Home parenteral nutrition for patients with advanced intraperitoneal cancers and gastrointestinal dysfunction.

J Surg Oncol. 1986; 33: 186-9.


A3.Bruera E, Legris MA, Kuehn N, et al.
Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer.

J Pain Symptom Manage. 1990; 5: 218-20.


A4.August DA, Thorn D, Fisher RL, et al.
Home parenteral nutrition for patients with inoperable malignant bowel obstruction.
JPEN J Parenter Enteral Nutr. 1991; 15: 323-7.

A5.Chapman C, Bosscher J, Remmenga S, et al.

A technique for managing terminally ill ovarian carcinoma patients.

Gynecol Oncol. 1991; 41: 88-91.


A6.Yan E, Bruera E.

Parenteral hydration of terminally ill cancer patients.

J Palliat Care. 1991; 7: 40-3.


A7.Burge FI.

Dehydration symptoms of palliative care cancer patients.

J Pain Symptom Manage. 1993; 8: 454-64.


A8.King LA, Carson LF, Konstantinides N, et al.

Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?

Gynecol Oncol. 1993; 51: 377-82.


A9.Fainsinger RL, Spachynski K, Hanson J, et al.

Symptom control in terminally ill patients with malignant bowel obstruction (MBO).

J Pain Symptom Manage. 1994; 9: 12-8.


A10.McCann RM, Hall WJ, Groth-Juncker A.

Comfort care for terminally ill patients. The appropriate use of nutrition and hydration.

JAMA. 1994; 272: 1263-6.


A11.Waller A, Hershkowitz M, Adunsky A.

The effect of intravenous fluid infusion on blood and urine parameters of hydration and on state of consciousness in terminal cancer patients.

Am J Hosp Palliat Care. 1994; 11: 22-7.


A12.Bruera E, Franco JJ, Maltoni M, et al.

Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation.

J Pain Symptom Manage. 1995; 10: 287-91.


A13.Bruera E, de Stoutz ND, Fainsinger RL, et al.

Comparison of two different concentrations of hyaluronidase in patients receiving one-hour infusions of hypodermoclysis.

J Pain Symptom Manage. 1995; 10: 505-9.


A14.Ellershaw JE, Sutcliffe JM, Saunders CM.

Dehydration and the dying patient.

J Pain Symptom Manage. 1995; 10: 192-7.


A15.Mercadante S.

Bowel obstruction in home-care cancer patients: 4 years experience.

Support Care Cancer. 1995; 3: 190-3.


A16.Mercadante S.

Parenteral nutrition at home in advanced cancer patients.

J Pain Symptom Manage. 1995; 10: 476-80.


A17.Musgrave CF, Bartal N, Opstad J.

The sensation of thirst in dying patients receiving i.v. hydration.

J Palliat Care. 1995; 11: 17-21.


A18.Benitez del Rosario MA, Salinas Martin A.

Hydration for control of syncope in palliative care.

J Pain Symptom Manage. 1997; 14: 5-6.


A19.Philip J, Depczynski B.

The role of total parenteral nutrition for patients with irreversible bowel obstruction secondary to gynecological malignancy.

J Pain Symptom Manage. 1997; 13: 104-11.


A20.Pironi L, Ruggeri E, Tanneberger S, et al.

Home artificial nutrition in advanced cancer.

J R Soc Med. 1997; 90: 597-603.


A21.Bruera E, Pruvost M, Schoeller T, et al.

Proctoclysis for hydration of terminally ill cancer patients.

J Pain Symptom Manage. 1998; 15: 216-9.


A22.Bruera E, Neumann CM, Pituskin E, et al.

A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydration.

Ann Oncol. 1999; 10: 1255-8.


A23.Torelli GF, Campos AC, Meguid MM.

Use of TPN in terminally ill cancer patients.

Nutrition. 1999; 15: 665-7.


A24.Cerchietti L, Navigante A, Sauri A, et al.

Hypodermoclysis for control of dehydration in terminal-stage cancer.

Int J Palliat Nurs. 2000; 6: 370-4.


A25.Lawlor PG, Gagnon B, Mancini IL, et al.

Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study.

Arch Intern Med. 2000; 160: 786-94.


A26.Mercadante S, Ripamonti C, Casuccio A, et al.

Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction.

Support Care Cancer. 2000; 8: 188-91.


A27.Morita T, Tei Y, Tsunoda J, et al.

Determinants of the sensation of thirst in terminally ill cancer patients.

Support Care Cancer. 2001; 9: 177-86.


A28.Morita T, Tei Y, Tsunoda J, et al.

Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients.

J Pain Symptom Manage. 2001; 22: 997-1006.


A29.Pasanisi F, Orban A, Scalfi L, et al.

Predictors of survival in terminal-cancer patients with irreversible bowel obstruction receiving home parenteral nutrition.

Nutrition. 2001; 17: 581-4.


A30.Bozzetti F, Cozzaglio L, Biganzoli E, et al.

Quality of life and length of survival in advanced cancer patients on home parenteral nutrition.

Clin Nutr. 2002; 21: 281-8.


A31.Morita T, Adachi I, et al.

Satisfaction with rehydration therapy for terminally ill cancer patients: concept construction, scale development, and identification of contributing factors.

Support Care Cancer. 2002; 10: 44-50.


A32.Morita T, Tei Y, Inoue S, et al.

Fluid status of terminally ill cancer patients with intestinal obstruction: an exploratory observational study.

Support Care Cancer. 2002; 10: 474-9.


A33.Morita T, Tei Y, Inoue S.

Agitated terminal delirium and association with partial opioid substitution and hydration.

J Palliat Med. 2003; 6: 557-63.